Eric Merle is currently working as Chief Business Innovation Officer at Genoskin. He has more than 15 years of experience in commercial roles at various global life science companies. He was most recently at Intrexon (XON), where he led the development of the Consumer Sector portfolio and business strategy as the senior director of strategic alliances and innovation. Prior to Intrexon, Eric Merle developed growth strategies for the Life Sciences division of SGS (SGSN), the world’s leading inspection, verification, testing, and certification company. He has also held commercial roles at Cellectis, Sigma Aldrich, Becton Dickinson, and Fisher Scientific.